You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal junction cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with

Enrolling by invitation
  • Gastric / Gastroesophageal Junction Adenocarcinoma
  • envafolimab and lenvatinib combined with paclitaxel-albumin
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Sep 3, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in La Jolla, Washington, Hackensack (CYNK-101, Pembrolizumab,

Recruiting
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • CYNK-101
  • +6 more
  • La Jolla, California
  • +2 more
Jul 12, 2022

Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)

Recruiting
  • Esophageal Cancer
  • Esophageal Neoplasms
  • hybrid PET/MRI
  • Milano, Italy
    Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
  • SHR-A1811
  • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
  • (no location specified)
Nov 6, 2023

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

Active, not recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Jul 4, 2023

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +30 more
  • Scottsdale, Arizona
  • +11 more
Apr 4, 2022

Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • Orange, California
  • +5 more
May 4, 2022

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 17, 2023

Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
  • (no location specified)
Jun 7, 2023

Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

Recruiting
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Gastroesophageal Junction
  • Docetaxel for injection (Albumin-bound)
  • Taxotere
  • Guangzhou, China
    Ethics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Esophageal Cancer Trial (Hypofractionated radiotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Hypofractionated radiotherapy
  • (no location specified)
Jan 18, 2023

Breast Cancer, Gastric/Gastroesophageal Junction Cancer Trial in Greenville (KN026)

Active, not recruiting
  • Breast Cancer
  • Gastric/Gastroesophageal Junction Cancer
  • Greenville, South Carolina
    Greenville Health System Center Institute
Nov 16, 2021

HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

Not yet recruiting
  • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 3, 2023

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)

Recruiting
  • Gastric Cancer
  • Microsatellite Instability
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Aug 3, 2022

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +23 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 5, 2022